ClinicalTrials.gg
Not yet recruitingNCT07886619BIRMAnieUpdated Oct 21, 2026

Implicit Bias in Intensive Care: Analysis and Assessment.

An observational study in Intensive Care, sponsored by University Hospital, Bordeaux. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by University Hospital, Bordeaux · Observational

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

This study uses clinical vignettes to explore how healthcare professionals make complex ethical decisions in intensive care settings. Participants evaluate several simulated scenarios, and their responses are analyzed to better understand decision making patterns.

Read the detailed description

The project investigates how clinicians assess and manage severe neurological cases through standardized vignette based simulations. The study aims to characterize variability in clinical judgments across different professional groups.

02

Conditions studied

  • Intensive Care

Keywords

  • Ethical decision
  • Intensive care
03

In context

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 803 studies on the registry; 194 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthcare professionals working in intensive care units

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthcare professionals working in intensive care units, including:

  • physicians (residents, fellows, attendings),
  • nurses,
  • nurse assistants.

Exclusion criteria

Exclusion Criteria:

  • No criteria
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthcare professional
06

What researchers measure

Primary outcomes

  1. Decision rating on a 4 point Likert scale

    Participants indicate how strongly they support a specific management option in each vignette

    Time frame: at inclusion day

Secondary outcomes

  1. Decision rating for ICU admission (Likert scale)

    Participants indicate how strongly they support an ICU admission in each vignette

    Time frame: at inclusion day

  2. Association between decision patterns and respondent characteristics

    The decisions made by participants will be evaluated based on several criteria related to their own characteristics. (profession, experience, age, etc.)

    Time frame: at inclusion day

07

Study locations

1 site
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07886619
Collaborators
Institut de Recherche et Documentation en Economie de la Santé, France
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Alexandre BOYER, Pr
Contact
alexandre.boyer@chu-bordeaux.fr
556795679 ext. +33
Florence FRANCIS-OLIVIERO, Dr
Contact
francis-oliviero@irdes.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion